These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
660 related items for PubMed ID: 11126681
1. [Immunophenotyping in acute leukemia: detection of minimal residual disease]. Pálóczi K, Nahajevszky S, Jakab K, Regéczy N, Gopcsa L, László E, Földi J. Orv Hetil; 2000 Nov 12; 141(46):2487-92. PubMed ID: 11126681 [Abstract] [Full Text] [Related]
2. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse. Li X, Du W, Liu W, Li X, Li H, Huang SA. APMIS; 2010 May 12; 118(5):353-9. PubMed ID: 20477810 [Abstract] [Full Text] [Related]
5. [Detection of minimal residual disease in acute leukemias by flow cytometry]. Scolnik MP. Medicina (B Aires); 2000 May 12; 60 Suppl 2():83-6. PubMed ID: 11188938 [Abstract] [Full Text] [Related]
6. Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease. Babusíková O, Glasová M, Kusenda J, Koníková E, Mésárosová A. Neoplasma; 1994 May 12; 41(6):305-13. PubMed ID: 7870213 [Abstract] [Full Text] [Related]
7. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire]. Inwoley KA, Sawadogo D, Mizero L, Salou M, Karim N, Sangaré A. Bull Soc Pathol Exot; 2004 May 12; 97(5):319-22. PubMed ID: 15787262 [Abstract] [Full Text] [Related]
8. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia. Babusíková O, Glasová M, Koníková E, Kusenda J. Neoplasma; 1996 May 12; 43(6):367-72. PubMed ID: 8996560 [Abstract] [Full Text] [Related]
9. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry. Al-Mawali A, Gillis D, Hissaria P, Lewis I. Am J Clin Pathol; 2008 Jun 12; 129(6):934-45. PubMed ID: 18480011 [Abstract] [Full Text] [Related]
10. [Detection of minimal residual disease in acute leukemias by immunophenotyping of bone marrow cells]. Deptała A, Widzyńska I, Kuratowska Z. Acta Haematol Pol; 1995 Jun 12; 26(4):403-11. PubMed ID: 8571742 [Abstract] [Full Text] [Related]
11. [Immunophenotyping of acute lymphatic leukemia: diagnostic aspects and clinical relevance]. Ludwig WD, Reiter A, Schott G, Schwartz S, Thiel E. Wien Klin Wochenschr; 1994 Jun 12; 106(8):231-2, 233-7. PubMed ID: 8023515 [Abstract] [Full Text] [Related]
16. [Study of antigenic profile of blasts in acute lymphoblastic leukemia: flow cytometric analysis of 152 cases]. Jmili NB, Souguir S, Yacoub S, Khelif A, Kortas M. Ann Biol Clin (Paris); 2009 Apr 15; 67(5):543-51. PubMed ID: 19789126 [Abstract] [Full Text] [Related]
17. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O. Neoplasma; 2007 Apr 15; 54(6):471-7. PubMed ID: 17949229 [Abstract] [Full Text] [Related]
18. Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia. Campana D, Coustan-Smith E. Best Pract Res Clin Haematol; 2002 Mar 15; 15(1):1-19. PubMed ID: 11987913 [Abstract] [Full Text] [Related]
19. [Clinical significance and prognostic detection of minimal residual disease in acute leukemias]. Deptała A, Widzyńska I, Kuratowska Z. Acta Haematol Pol; 1995 Mar 15; 26(4):413-20. PubMed ID: 8571743 [Abstract] [Full Text] [Related]
20. Acute leukaemia immunophenotyping in bone-marrow routine sections. Pileri SA, Ascani S, Milani M, Visani G, Piccioli M, Orcioni GF, Poggi S, Sabattini E, Santini D, Falini B. Br J Haematol; 1999 May 15; 105(2):394-401. PubMed ID: 10233410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]